
Join us on August 12th from 12:30 - 3:30 pm at Kiln's Salt Lake City location to donate with ARUP Blood Services. All members of the community are welcome! Sign up for an appointment slot here: lnkd.in/gGvQZQRk

BioHive is a collective representing the life science & healthcare innovation ecosystem of Utah’s economy. Share your story and tag ➡️ #BioHive

Join us on August 12th from 12:30 - 3:30 pm at Kiln's Salt Lake City location to donate with ARUP Blood Services. All members of the community are welcome! Sign up for an appointment slot here: lnkd.in/gGvQZQRk

Industry News Alert! 🗞 Renew Biotechnologies Welcomes Steven Abbott as Chief Operating Officer to Lead Wasatch BioLabs' Transition to Commercial Operations: prnewswire.com/news-releases…

Thrilled to be recognized by @Time as one of America's Best Midsize Companies of 2024! This recognition reflects our commitment to #innovation and excellence in genetic testing and precision medicine 🧬. See the full list: time.com/collection/americas… #companyculture

Industry News Alert! ⬇ EVŌQ Nano announces EVQ-218 Nanoparticle to address critical gaps in the fight against antibiotic-resistant bacteria. Read more: evoqnano.com/evoq-nanos-evq-… #antibioticresistance #lifesciences #biotechinnovation

BioHive is seeking a returner! A returner is someone looking to rejoin the workforce after an elected career break for any of the following reasons: infirmary/illness, parental leave, caregiving, military service, and/or unretirement. Apply here: lnkd.in/dUwAHrCR


Inherent Biosciences, Inc. has secured a $1.9 million Fast-Track SBIR grant from the The National Institutes of Health to further its mission of raising the standard of care in reproductive health! 👏 #reproductivehealth #epigenetics #biohive #utah newswire.com/news/inherent-b…

.@Halia_Tx yesterday announced the opening of its new 20,000 square foot headquarters located at The Summit, on 3900 North Traverse Mountain Blvd., in Lehi, Utah. #BioHive prnewswire.com/news-releases…

Leah Frautschy is the VP, Clinical Manufacturing at Denali Therapeutics. In this #BioHive Talk, she discusses the significance of cultivating diverse teams and provides insights into the strategies for fostering such teams within your organization. 📺 youtu.be/NnwFqN8chjc

Thank you @slcecondev for helping connect the #BioHive to our incredible educators in #SaltLakeCity! 👏 Great work, @seek_labs, @RecursionPharma and @Checkerspot_ ! Together we can do amazing things. 📈
An incredible day at the Teacher STEM Super Tour! Teachers and industry partners engaged in meaningful discussions about STEM career paths for students. The event featured Seek Labs, Recursion, and Checkerspot, showcasing the exciting opportunities for our young people!

Predicting protein targets for ~36 billion compounds takes a massive team effort. We sat down with our VP of #digitalchemistry @ss_mackinnon to learn more about what went into accomplishing this feat. Read more: recursion.com/news/a-deep-di… #biotech #artificialintelligence #AlphaFold #deeplearning #chemistry #techbio #ML #AI

.@myriadgenetics and @Intermountain are teaming up to provide access to ComboMATCH trials! 👏 Backed by @theNCI & @eaonc, these trials strive to uncover effective anti-cancer drug combinations. #biohive #therapeutics #clinicaltrials #utah buff.ly/3DQ3TAR

Discover why quality control is essential for your health care startup on August 23! Led by Lars Mouritsen and sponsored by Avendium, join @AltitudeLab to gain valuable insights and strategies for FDA approval and successful product launch. 🚀 Register: bit.ly/44XZ7wE

Halia Therapeutics announced today the completion of enrollment for its phase I clinical trial of HT-6184 for chronic inflammation. See the news release here: prn.to/45jmv8k

Congratulations to the #lifescience industry professionals that received a 2023 @UtahBusiness HR Achievement Award! Britt McPartland, SHRM-SCP, Senior Director, People & Site Operations, Pathos Mike Voigt, Chief Human Resources Officer, @MeritMedical utahbusiness.com/events/hr-a…

Alucent Biomedical announced that the FDA granted an Investigational Device Exemption (IDE) for a U.S. clinical study of AlucentNVS, a unique light-activated, drug-coated balloon catheter technology. #biohive #ide #vasculardisease Read more: buff.ly/45fOCoz